Enter the first few characters of Company and click 'Go'
Audited Results of Natco Pharma Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
2,351 |
1,767.80 |
1,653.50 |
1,790.20 |
1,986.30 |
Manufacturing Expenses |
81.90 |
76.40 |
59.40 |
62.40 |
59.60 |
Personnel Expenses |
425.70 |
410.10 |
380 |
356.10 |
340.20 |
Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Administrative Expenses |
431.60 |
498.20 |
268.40 |
367.70 |
393.70 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
1,506.30 |
1,554.80 |
1,235.90 |
1,212.20 |
1,169.80 |
Operating Profit |
844.70 |
213 |
417.60 |
578 |
816.50 |
Other Recurring Income |
85.50 |
94.60 |
101.10 |
123.80 |
129.80 |
Adjusted PBDIT |
930.20 |
307.60 |
518.70 |
701.80 |
946.30 |
Financial Expenses |
8.60 |
13.30 |
11.30 |
20.60 |
18.80 |
Depreciation |
150.90 |
138.40 |
115.20 |
98.10 |
80.10 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
770.70 |
155.90 |
392.20 |
583.10 |
847.40 |
Tax Charges |
133.60 |
16.80 |
82.70 |
108.60 |
180.30 |
Adjusted PAT |
637.10 |
139.10 |
309.50 |
474.50 |
667.10 |
Non Recurring Items |
1.70 |
9.80 |
-0.30 |
-5.20 |
0 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
637.10 |
139.10 |
309.50 |
474.50 |
667.10 |
Equity Dividend |
100.40 |
82.10 |
113.90 |
101.20 |
73 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
3,125.50 |
2,586.80 |
2,517.80 |
2,348.70 |
2,046.10 |